News
1h
Zacks Investment Research on MSNCan Unity Software's AI Engine Vector Fuel Long-Term Growth?Unity Software Inc. U enhanced and expanded its digital platform capabilities by launching Unity Vector in early 2025. Vector ...
ZTS delivered second-quarter 2025 adjusted earnings (excluding one-time items) of $1.76 per share, which surpassed the Zacks ...
Unity has published its financial results for the second quarter of its fiscal year, experiencing slight drops in ...
As ever, the beginning of a campaign means new strips for all 20 Premier League clubs and that has stirred The Athletic’s ...
Tidus, Cloud, or someone else? Here’s our ranking of the Commander precons from the Magic: The Gathering x Final Fantasy set, ...
The Nasdaq Composite returned 12% annually in the last two decades, and the gains should continue as technology stocks ...
Shares of Unity Software (U) fell about 4% premarket on Wednesday despite second quarter results beating estimates.
ZTS eyes an earnings beat as companion animal drugs like Simparica Trio and Apoquel are expected to drive Q2 revenue gains.
Chanel and Pandora have become the latest fashion giants to disclose breaches of customer data, in what appear to be attacks ...
1d
XDA Developers on MSN5 things I wish I'd considered before ditching my Adobe subscriptionThinking about canceling your Adobe subscription? Consider these 5 important factors before making the leap, from learning ...
Sonnedix and Prosolia have acquired projects, while Iberdrola has signed a 34MW PPA with Burger King covering 109MW total.
2d
Clinical Trials Arena on MSNHansa’s Idefirix shows potential as pre-treatment to ElevidysHansa Biosciences’ Idefirix (imlifidase) has reduced patients’ antibodies to a level that allows dosing in patients with Duchenne muscular dystrophy (DMD) with Sarepta and Roche’s Elevidys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results